With the approval, FDA granted SpringWorks a rare pediatric disease priority review voucher.
Industry Outlook 2025: Experts Weigh in on the Most Impactful Trends for Industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback